Amit Gupta Sells 9,640 Shares of Cardlytics (NASDAQ:CDLX) Stock

Cardlytics, Inc. (NASDAQ:CDLX) CEO Amit Gupta sold 9,640 shares of the firm’s stock in a transaction on Monday, July 6th. The stock was sold at an average price of $4.39, for a total transaction of $42,319.60. Following the completion of the sale, the chief executive officer owned 113,850 shares in the company, valued at $499,801.50. This represents a 7.81% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Amit Gupta also recently made the following trade(s):

• On Thursday, July 2nd, Amit Gupta sold 6,498 shares of Cardlytics stock. The shares were sold at an average price of $4.39, for a total transaction of $28,526.22.

Cardlytics Stock Performance

NASDAQ CDLX opened at $4.26 on Wednesday. Cardlytics, Inc. has a twelve month low of $4.06 and a twelve month high of $32.80. The stock has a market cap of $24.75 million, a PE ratio of -0.24 and a beta of 0.61. The firm has a 50-day simple moving average of $6.16 and a 200 day simple moving average of $8.67.

Analyst Ratings Changes

A number of equities research analysts have weighed in on CDLX shares. Lake Street Capital set a $10.00 price target on shares of Cardlytics in a research note on Friday, May 8th. Wall Street Zen downgraded shares of Cardlytics from a “hold” rating to a “sell” rating in a report on Saturday, June 13th. Weiss Ratings reissued a “sell (e+)” rating on shares of Cardlytics in a research note on Friday, April 10th. Finally, Needham & Company LLC reissued a “hold” rating on shares of Cardlytics in a research report on Thursday, June 18th. Two equities research analysts have rated the stock with a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Reduce” and an average target price of $10.00.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in CDLX. Renaissance Technologies LLC boosted its stake in shares of Cardlytics by 108.3% in the 1st quarter. Renaissance Technologies LLC now owns 112,500 shares of the company’s stock valued at $118,000 after purchasing an additional 58,500 shares in the last quarter. Virtu Financial LLC acquired a new stake in shares of Cardlytics during the 4th quarter worth about $39,000. Invesco Ltd. lifted its holdings in Cardlytics by 38.1% during the 4th quarter. Invesco Ltd. now owns 170,122 shares of the company’s stock valued at $196,000 after purchasing an additional 46,973 shares during the last quarter. Barclays PLC boosted its position in Cardlytics by 31,167.6% in the fourth quarter. Barclays PLC now owns 55,969 shares of the company’s stock valued at $64,000 after buying an additional 55,790 shares in the last quarter. Finally, Goldman Sachs Group Inc. boosted its position in Cardlytics by 15.1% in the fourth quarter. Goldman Sachs Group Inc. now owns 109,001 shares of the company’s stock valued at $125,000 after buying an additional 14,273 shares in the last quarter. 68.10% of the stock is owned by institutional investors.

About Cardlytics

Cardlytics, Inc operates a purchase intelligence and marketing platform that connects advertisers with consumers through bank and credit card transaction data. The company partners with financial institutions to analyze anonymized purchase information, enabling brands to deliver highly targeted offers and rewards directly to customers’ online and mobile banking channels. By leveraging real-time insights into consumer spending habits, Cardlytics helps marketers optimize campaign performance and measure return on ad spend more accurately than traditional digital advertising methods.

At the core of Cardlytics’ offering is its proprietary purchase intelligence engine, which aggregates and anonymizes transaction data from partner banks and credit unions.